CITF just announced that COVID-19 vaccination for children will be POSTPONED until a later time.
Here is what you need to know!
COVID-19 Vaccination For Children : One Vaccine Approved!
On 15 June 2021, Malaysia approved the Pfizer COMIRNATY vaccine for children of 12 to 17 years in age.
CITF also opened up registration of children for COVID-19 vaccination through MySejahtera and the Vaksin COVID website.
COVID-19 Vaccination For Children Postponed For Now!
On 22 July 2021, CITF (COVID-19 Immunisation Task Force) announced that COVID-19 vaccination for children will be postponed for the time being.
“This includes SPM candidates (and is meant to) prevent any risk of myocarditis and pericarditis (heart inflammation) as reported by teenagers in the United States who have received their second dose of Covid-19 vaccines.“
The government will only administer the Pfizer vaccine to adolescents with certain underlying health conditions, like cancer, chronic lung disease and co-morbidities like diabetes.
The Malaysia Health Ministry is finalising clinical guidelines for children and teenagers with such pre-existing conditions, as they are at higher risk of hospitalisation or death if they contract COVID-19.
Children of between 12 and 17 years of age can still register for vaccination, but no vaccine appointment will be given out.
Teenagers who are 18 years of age by 31 December 2021 will continue to receive their COVID-19 vaccine appointments.
COVID-19 Vaccination For Children : Risk Of Myocarditis / Pericarditis
Unfortunately, both Pfizer and Moderna mRNA vaccines are now known to cause cases of myocarditis and pericarditis in teenagers.
- myocarditis : inflammation of the heart muscle
- pericarditis : inflammation of the outer lining of the heart
These cases are rare – just 1,148 cases were reported in the United States (as of 19 July 2021) amongst people 30 years old or younger, of which 674 cases of myocarditis or pericarditis were confirmed.
That was after over 20 million Pfizer COMIRNATY doses were given to adolescents and young adults. So the risk of developing myocarditis / pericarditis is approximately :
- 6 cases for every 100,000 doses.
- 1 case for every 17,400 doses
The confirmed cases in the United States have occurred :
- mostly in male adolescents and young adults age 16 years of older
- more often after getting the second dose
- typically occurs within a few days after receiving the vaccine
People who develop myocarditis or pericarditis will experience symptoms like :
- chest pain
- shortness of breath
- heart palpitations / pounding heart
Please Support My Work!
Name : Adrian Wong
Bank Transfer : CIMB 7064555917 (Swift Code : CIBBMYKL)
Credit Card / Paypal : https://paypal.me/techarp
Thank you in advanced! ❤️
- How Chinese Vaccine Propaganda Hobbles Vaccination Efforts
- Fact Check : Ivermectin Triple Therapy By Professor Borody
- CITF : Walk-In Vaccination Details To Be Announced LATER!
- Malaysia : +3 Million Sinovac Doses, Private Sale Soon!
- Walk-In Vaccination In Malaysia From 1 August Onwards?
- What To Do Before, During + After COVID-19 Vaccination?
- Delta Variant Can Infect In Seconds : How To Prevent That?
- Scam Alert : Ziverdo Kit To Treat COVID-19!
- Fact Check : LifeSiteNews Promotion Of Ivermectin + FLCCC